EUVIMEDEUVIMED entdecken
Crossref

Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross‐sectional study in 684 melanoma patients

Esperanza Manrique-Silva iD, Millán-Esteban David, Aguerralde-Martin Maider, Zaida García-Casado, Ruggero Moro, Celia Requena, Victor Través, Amaya Virós, Rajiv Kumar, Eduardo Nagore iD

Pigment Cell & Melanoma Research · 2024

DOI: 10.1111/pcmr.13155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2024. Verfasst von Esperanza Manrique-Silva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Doctorado, Universidad Católica de Valencia "San Vicente Mártir", València, Spain. Hauptthemen laut MEDLINE: Melanoma, Promoter Regions, Genetic, Telomerase. Die Arbeit nennt 27 Literaturangaben. Gefördert von: PPRC-2018-36 of the European Academy of Dermatology and Venereology (EADV), Asociación Española Contra el Cáncer-Valencia (AECC, "Ayudas predoctorales en oncología" grant).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Differences in survival according to the pTERT mutation subtypes (−124C > T, −146C > T, and tandem −138_139CC > TT) have been observed. The present study aimed to describe the clinical as the histopathological and molecular cutaneous melanoma features according to the presence of the three most prevalent pTERT mutation subtypes (−124C > T, −146C > T, and tandem −138_139CC > TT). A retrospective cross‐sectional study including 684 patients was designed, and a Partial Least‐Squares Discriminant Analysis (PLS‐DA) was performed. After the PSL‐DA, it was observed that the tandem −138_139CC > TT subtype differs from the other subtypes. The model demonstrated that the −124C > T and the −138_139 CC > TT subtypes were associated with fast‐growing melanomas (OR 0.5, CI 0.29–0.86, p = .012) and with Breslow >2 mm (OR 0.6, CI 0.37–0.97, p = .037), compared to the −146C > T mutation. Finally, the −124C > T appeared to be more associated with the presence of TILs (non‐brisk) than the −146C > T (OR 0.6, CI 0.40–1.01, p = .05). These findings confirmed that the −124C > T and the tandem −138_139 CC > TT subtypes are both highly associated with the presence of features of aggressiveness; however, only the −124C > T was highly associated with TILs. This difference could explain the worse survival rate associated with the tandem −138_139CC > TT mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaPromoter Regions, GeneticTelomeraseFemaleHumansMaleCross-Sectional StudiesMutationRetrospective StudiesSkin Neoplasms

Stichwörter der Autor:innen

biomarkersgeneticsmelanomaoncologytranslational research

Substanzen

TelomeraseTERT protein, human

Autor:innen und Institutionen

  • Escuela de Doctorado, Universidad Católica de Valencia "San Vicente Mártir", València, Spain.
  • Department of Dermatology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • School of Medicine, Universidad Católica de Valencia "San Vicente Mártir", València, Spain.
  • Máster de Ingeniería de Análisis de Datos, Toma de Decisiones y Mejora de Procesos, Universidad Politécnica de Valencia, Valencia, Spain.
  • Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Instituto Dermatológico Dr. Alonso, Hospital Vithas Valencia 9 de Octubre, Spain.

ORCID-Profile: Esperanza Manrique-Silva, Eduardo Nagore

Förderung

  • PPRC-2018-36 of the European Academy of Dermatology and Venereology (EADV)
  • Asociación Española Contra el Cáncer-Valencia (AECC, "Ayudas predoctorales en oncología" grant)

Zitieren

APA

Manrique-Silva, E., David, M. E., Maider, A. M., García-Casado, Z., Moro, R., Requena, C., Través, V., Virós, A., Kumar, R., & Nagore, E. (2024). Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross‐sectional study in 684 melanoma patients. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13155

Vancouver

Manrique-Silva E, David ME, Maider AM, García-Casado Z, Moro R, Requena C, et al. Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross‐sectional study in 684 melanoma patients. Pigment Cell & Melanoma Research. 2024. doi:10.1111/pcmr.13155

BibTeX
@article{ManriqueSilva2024,
  author = {Manrique-Silva, Esperanza and David, Millán-Esteban and Maider, Aguerralde-Martin and García-Casado, Zaida and Moro, Ruggero and Requena, Celia and Través, Victor and Virós, Amaya and Kumar, Rajiv and Nagore, Eduardo},
  title = {Clinical, histological, and molecular differences in melanoma due to different TERT promoter mutations subtypes. A retrospective cross‐sectional study in 684 melanoma patients},
  journal = {Pigment Cell & Melanoma Research},
  year = {2024},
  doi = {10.1111/pcmr.13155}
}
Kostenlos starten →